By contrast, in ovarian cancer mouse models it has been demonstrated that Trp53 inactivation results in invasive tumors but tumor development is accelerated in mice with concomitant inactivation of Brca1 and Trp5354. Here, BRCA1 is linked to ovarian carcinoma.